Fructose is one of the key dietary catalysts in the development of non-alcoholic fatty liver
disease (NAFLD). NAFLD comprises a complex disease spectrum, including steatosis (fatty …

A variety of dietary natural products have shown hepatoprotective effects. Increasing
evidence has also demonstrated that gut microorganisms play an important role in the …

Background & Aims Dysbiosis of the intestinal microbiota has been associated with
nonalcoholic fatty liver disease (NAFLD). We investigated whether administration of a …

Scope To compare the intestinal anti‐inflammatory effects of two probiotics Lactobacillus
fermentum and Lactobacillus salivarius in mouse colitis, focusing on their impact on selected …

Obesity is one of the main features of metabolic syndrome, where a low-grade chronic
inflammation and gut dysbiosis contribute to the development of the related metabolic …

Simple Summary Short-chain fatty acids are produced by the bacteria present in the large
intestine. They are digestion products of fiber-containing foods and have many effects. Short …

Purpose Consumption of fructose has repeatedly been discussed to be a key factor in the
development of health disturbances such as hypertension, diabetes type 2, and non …

High consumption of fructose and high-fructose corn syrup is related to the development of
obesity-associated metabolic diseases, which have become the most relevant diet-induced …

Noncaloric artificial sweeteners (NAS) are extensively introduced into commonly consumed
drinks and foods worldwide. However, data on the health effects of NAS consumption …

The aim of the present study was to investigate alterations in gut microbiota associated with
hypercholesterolemia and treatment with atorvastatin, a commonly prescribed cholesterol …